BioMedical Technology Solutions Holdings (BMTL.OB) Strengthens Board in Preparation for Expansion with the Addition of Manny Losada

BioMedical Technology Solutions Holdings, Inc. (“BMTS”) announced today that industry-wide respected businessman, Manny Losada, has agreed to join the BMTS Board of Directors. Manny brings more than 25 years of domestic and international experience to BMTS in the Company’s quest to take the Demolizer® II to new levels in sales and rentals.

Manny has proven his ability to produce at a various large companies throughout his career including Medical Actions Industries, B. Braun Medical, Henry Schein and Caligor/MicrobioMedics, Inc. Mr. Losada was a team leader in mergers and acquisitions during his time at Caligor/MicrobioMedics by successfully completing five acquisitions of regional hospital suppliers to support a 5-year, double digit company growth rate.

Presently, Manny is the President of MedPro Associates. MedPro is an industry giant representing many organizations that specialize in healthcare and sell their products either through distribution agreements or directly to consumers within the market. Mr. Losada is responsible for the strategic growth and business developments of MedPro. With his extensive global experience, Mr. Losada will be integral to the growth of BioMedical Technology Solutions, the wholly-owned subsidiary of BMTS through which BMTS operates.

Don Cox, President and CEO of BMTS, stated, “We are truly excited that Manny has agreed to join our Board of Directors. With his tremendous experience and proven leadership, Manny understands what is needed to develop long term strategic growth. I have gotten to know Manny very well over the past few years. He is a strategic thinker that has a depth of the knowledge on the diverse healthcare industries that is extremely difficult to find. As we continue our expansion both domestically and internationally, Manny is going to be an invaluable resource to our team.”

BioMedical Technology Solutions appears to be getting ready to ramp up business. In mid-August, BioMedical announced that Gex Richardson resigned from the positions of Director and General Counsel to aggressively pursue international distribution and domestic rentals of the Demolizer® II on a full-time basis. Last week, the Company announced the returning of a half a million warrants by Mr. Cox for no consideration. Previous to those press releases, the Company announced more sales of the System to U.S. HealthWorks and the U.S. Department of Veteran Affairs. Mr. Cox also mentioned in these press releases that there have been ongoing negotiations with large corporations. These press releases and comments within in conjunction with the fact that U.S. HealthWorks had originally been doing a “trial” of the Demolizer® II System in select markets, that was admittedly a success, poses the question of “What is in store for BioMedical Technology Solutions and Demolizer® II sales and rentals?” Never one to speculate too heavily, but it seems as if pieces of the puzzle are pulling together. Time will tell.

More information on BioMedical Technology Solutions Holdings, Inc., the Demolizer II System and the investment opportunity presented by BMTL can be found on the Company’s website at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Tactical Air Defense Services Buying Air 1 Flight Support

Tactical Air Defense Services Buying Air 1 Flight Support(0)

Tactical Air Defense Services, Inc. (Pinksheets: TADF) said Friday morning that it has signed a Letter of Intent to acquire 100 percent of Air 1 Flight Support, Inc. a privately-held provider of aircraft maintenance, refueling and support services headquartered in Denison, Texas, in an all-stock transaction. Tactical Air Defense Services is certified by the U.S.

Electronic Control Security Lands Prime Government Contract

Electronic Control Security Lands Prime Government Contract(0)

Shares of Electronic Control Security, Inc. (OTCBB: EKCS) have soared ahead in Friday morning trading after the company said that it has received a prime contract award from the Department of the Navy, Space and Naval Warfare Systems Center Atlantic (SPAWAR). The Clifton, New Jersey-based provider of integrated entry control and perimeter security systems said

Brightcove Shares Nosedive on Weak 2013 Guidance

Brightcove Shares Nosedive on Weak 2013 Guidance(0)

Coming up on its one-year anniversary of being a public entity, shares of Brightcove, Inc. (NASDAQ: BCOV) printed all-time lows after delivering its fourth-quarter and full 2012 year earnings and a weak outlook for 2013. The provider of cloud-based video streaming services reported total revenue for the fourth quarter of 2012 of $24.3 million, an

Balqon Lithium Battery System Installed in Hybrid Yacht

Balqon Lithium Battery System Installed in Hybrid Yacht(0)

Investors are used to hearing about lithium battery technologies for use in automobiles, but Balqon Corporation (OTCBB: BLQN) is taking them from the street to the water. On Friday, the Harbor City, California-based developer of electric vehicles, drive systems and lithium battery storage systems said that it has delivered and installed its HIQAP high energy

NCAL Bancorp and Grandpoint Capital Terminate Merger Agreement

NCAL Bancorp and Grandpoint Capital Terminate Merger Agreement(0)

NCAL Bancorp (OTCQB: NCAL) and Grandpoint Capital, Inc. said in a joint announcement Tuesday that the two companies have terminated their definitive agreement to merge. Under the agreement, which was entered into in June 2012, Grandpoint was to acquire NCAL Bancorp and its subsidiary National Bank of California. Los Angeles, California-based NCAL and Bank of

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.